1
|
Bourdel-Marchasson I, Ostan R, Regueme SC, Pinto A, Pryen F, Charrouf Z, d’Alessio PA, Roubaud Baudron C, Guerville F, Durrieu J, Donini LM, Franceschi C, Valentini L. Quality of Life: Psychological Symptoms-Effects of a 2-Month Healthy Diet and Nutraceutical Intervention; A Randomized, Open-Label Intervention Trial (RISTOMED). Nutrients 2020; 12:nu12030800. [PMID: 32197408 PMCID: PMC7146172 DOI: 10.3390/nu12030800] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2020] [Revised: 03/01/2020] [Accepted: 03/16/2020] [Indexed: 01/15/2023] Open
Abstract
Depression symptoms and lower health-related quality of life (HRQoL) are associated with inflammation. This multicenter dietary intervention was shown to reduce inflammation in older people. This was the main outcome. Here, we describe the effects on HRQoL, anxiety, and depressive symptoms according to inflammation status. Overall, 125 healthy older subjects (65–80 year) were recruited (Italy, France, and Germany) and randomized into four arms (A, Healthy diet (HD); B, HD plus De Simone Formulation probiotic blend; C, HD plus AISA d-Limonene; D, HD plus Argan oil). The HD was weight maintaining, rich in antioxidant vitamins, polyphenols, polyunsaturated fatty acids (n6: n3 ratio = 3:1), and fiber. Data on inflammatory parameters, mental (MCS) and physical (PCS) component summaries of HRQoL (SF−36), anxiety symptoms (STAI state), and depressive symptoms (CES-D) were collected before and after 56 days of intervention. Body fat mass proportion (BFM) was considered a co-variable. A decrease of CES-D score was seen in the four arms (A: −40.0%, p = 0.001; B: −32.5%, p = 0.023; C: −42.8%, p = 0.004; and D: −33.3%, p = 0.21). Within the subgroups of subjects with medium/high inflammation a similar decrease in CES-D score occurred in all groups (A: −44.8%, p = 0.021; B, −46.7%, p = 0.024; C, −52.2%, p = 0.039; D, −43.8%, p = 0.037). The effect of interventions on CES-D was not related to baseline inflammation. MCS-HRQoL improved in A and C. There was no change in anxiety or PCS-HRQoL. In this trial with no control group, a decrease in depressive symptoms in healthy older volunteers was observed after a 2-month healthy diet intervention, independently of inflammation but with possible limitations due to participation.
Collapse
Affiliation(s)
- Isabelle Bourdel-Marchasson
- CRMSB UMR 5536, Université Bordeaux/CNRS, F−33000 Bordeaux, France
- CHU Bordeaux, Pôle de Gérontologie, Bordeaux, F−33000 Bordeaux, France; (S.C.R.); (C.R.B.); (F.G.); (J.D.)
- Correspondence: ; Tel.: +33-55-765-6571
| | - Rita Ostan
- Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, 40126 Bologna, Italy; (R.O.); (C.F.)
| | - Sophie C Regueme
- CHU Bordeaux, Pôle de Gérontologie, Bordeaux, F−33000 Bordeaux, France; (S.C.R.); (C.R.B.); (F.G.); (J.D.)
| | - Alessandro Pinto
- Experimental Medicine Department, Sapienza University of Rome, 00185 Rome, Italy; (A.P.); (L.M.D.)
| | - Florence Pryen
- Mendes SA, Via Giacometti 1, CH−6900 Lugano, Switzerland;
| | - Zoubida Charrouf
- Department of Chemistry, University Mohammed V, Rabat BP 1014, Morocco;
| | - Patrizia A d’Alessio
- AISA (Anti-Inflammatory Senescence Actives) Therapeutics, Genopole Entreprises 91058 Evry, France;
| | - Claire Roubaud Baudron
- CHU Bordeaux, Pôle de Gérontologie, Bordeaux, F−33000 Bordeaux, France; (S.C.R.); (C.R.B.); (F.G.); (J.D.)
- Université Bordeaux, INSERM UMR 1053, BaRITon, F−33000 Bordeaux, France
| | - Florent Guerville
- CHU Bordeaux, Pôle de Gérontologie, Bordeaux, F−33000 Bordeaux, France; (S.C.R.); (C.R.B.); (F.G.); (J.D.)
| | - Jessica Durrieu
- CHU Bordeaux, Pôle de Gérontologie, Bordeaux, F−33000 Bordeaux, France; (S.C.R.); (C.R.B.); (F.G.); (J.D.)
| | - Lorenzo M Donini
- Experimental Medicine Department, Sapienza University of Rome, 00185 Rome, Italy; (A.P.); (L.M.D.)
| | - Claudio Franceschi
- Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, 40126 Bologna, Italy; (R.O.); (C.F.)
- Department of Applied Mathematics, Lobachevsky University, Nizhny Novgorod 603950, Russia
| | - Luzia Valentini
- Department Gastroenterology and Hepatology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany;
- Neubrandenburg Institute of Evidence-Based Dietetics (NIED), University of Applied Sciences, 17033 Neubrandenburg, Germany
| |
Collapse
|
2
|
Ostan R, Béné MC, Spazzafumo L, Pinto A, Donini LM, Pryen F, Charrouf Z, Valentini L, Lochs H, Bourdel-Marchasson I, Blanc-Bisson C, Buccolini F, Brigidi P, Franceschi C, d'Alessio PA. Impact of diet and nutraceutical supplementation on inflammation in elderly people. Results from the RISTOMED study, an open-label randomized control trial. Clin Nutr 2015; 35:812-8. [PMID: 26249791 DOI: 10.1016/j.clnu.2015.06.010] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2015] [Revised: 05/22/2015] [Accepted: 06/26/2015] [Indexed: 01/09/2023]
Abstract
BACKGROUND & AIMS Eating habits may influence the life span and the quality of ageing process by modulating inflammation. The RISTOMED project was developed to provide a personalized and balanced diet, enriched with or without nutraceutical compounds, to decrease and prevent inflammageing, oxidative stress and gut microbiota alteration in healthy elderly people. This paper focused on the effect on inflammation and metabolism markers after 56 days of RISTOMED diet alone or supplementation with three nutraceutical compounds. METHODS A cohort of 125 healthy elderly subjects was recruited and randomized into 4 arms (Arm A, RISTOMED diet; Arm B, RISTOMED diet plus VSL#3 probiotic blend; Arm C, RISTOMED diet plus AISA d-Limonene; Arm D, RISTOMED diet plus Argan oil). Inflammatory and metabolism parameters as well as the ratio between Clostridium cluster IV and Bifidobacteria (CL/B) were collected before and after 56 days of dietary intervention, and their evolution compared among the arms. Moreover, participants were subdivided according to their baseline inflammatory parameters (erythrocytes sedimentation rate (ESR), C-Reactive Protein, fibrinogen, Tumor Necrosis Factor-alfa (TNF-α), and Interleukin 6) in two clusters with low or medium-high level of inflammation. The evolution of the measured parameters was then examined separately in each cluster. RESULTS Overall, RISTOMED diet alone or with each nutraceutical supplementation significantly decreased ESR. RISTOMED diet supplemented with d-Limonene resulted in a decrease in fibrinogen, glucose, insulin levels and HOMA-IR. The most beneficial effects were observed in subjects with a medium-high inflammatory status who received RISTOMED diet with AISA d-Limonene supplementation. Moreover, RISTOMED diet associated with VSL#3 probiotic blend induced a decrease in the CL/B ratio. CONCLUSIONS Overall, this study emphasizes the beneficial anti-inflammageing effect of RISTOMED diet supplemented with nutraceuticals to control the inflammatory status of elderly individuals.
Collapse
Affiliation(s)
- R Ostan
- Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Via San Giacomo 12, 40126 Bologna, Italy
| | - M C Béné
- Hematology Laboratory, University Hospital CHU, 9 Quai Moncousu, 44000 Nantes, France
| | - L Spazzafumo
- Biostatistical Center INRCA, Via S. Margherita 5, 60100 Ancona, Italy
| | - A Pinto
- Experimental Medicine Department, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy
| | - L M Donini
- Experimental Medicine Department, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy
| | - F Pryen
- Institute for Organic Synthesis and Photoreactivity, National Research Council of Italy, CNR, (ISOF), Via P. Gobetti 101, 40129 Bologna, Italy
| | - Z Charrouf
- Department of Chemistry, University Mohammed V-Agdal, Rabat, Morocco
| | - L Valentini
- Department Gastroenterology and Hepatology, Charité-Universitätsmedizin Berlin, CCM, Charitéplatz 1, 10117 Berlin, Germany
| | - H Lochs
- Medical University of Innsbruck, Innrain 52, 6020 Innsbruck, Austria
| | - I Bourdel-Marchasson
- CHU Bordeaux, Clinical Gerontology, France; CNRS, RMSB, UMR 5536, France; University Bordeaux, RMSB, UMR 5536, Bordeaux, France
| | - C Blanc-Bisson
- CHU Bordeaux, Clinical Gerontology, France; CNRS, RMSB, UMR 5536, France; University Bordeaux, RMSB, UMR 5536, Bordeaux, France
| | - F Buccolini
- R&D, VoxNet CEO, Via Giovanni Paisiello 32, 00198 Rome, Italy
| | - P Brigidi
- Department of Pharmacy and Biotechnology, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy
| | - C Franceschi
- Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Via San Giacomo 12, 40126 Bologna, Italy; IRCCS, Institute of Neurological Sciences, Via Altura 3, 40139 Bologna, Italy; National Research Council of Italy, CNR, Institute for Organic Synthesis and Photoreactivity (ISOF), Via P. Gobetti 101, 40129 Bologna, Italy
| | - P A d'Alessio
- Biopark Campus Cancer, 1 mail du Pr Georges Mathé, 94807 Villejuif, France.
| |
Collapse
|
3
|
Valentini L, Pinto A, Bourdel-Marchasson I, Ostan R, Brigidi P, Turroni S, Hrelia S, Hrelia P, Bereswill S, Fischer A, Leoncini E, Malaguti M, Blanc-Bisson C, Durrieu J, Spazzafumo L, Buccolini F, Pryen F, Donini LM, Franceschi C, Lochs H. Impact of personalized diet and probiotic supplementation on inflammation, nutritional parameters and intestinal microbiota - The "RISTOMED project": Randomized controlled trial in healthy older people. Clin Nutr 2014; 34:593-602. [PMID: 25453395 DOI: 10.1016/j.clnu.2014.09.023] [Citation(s) in RCA: 73] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2014] [Revised: 07/23/2014] [Accepted: 09/29/2014] [Indexed: 02/06/2023]
Abstract
OBJECTIVES To assess the impact of a personalized diet, with or without addition of VSL#3 preparation, on biomarkers of inflammation, nutrition, oxidative stress and intestinal microbiota in 62 healthy persons aged 65-85 years. DESIGN Open label, randomized, multicenter study. PRIMARY ENDPOINT High-sensitivity C-reactive protein. SETTING Community. INTERVENTIONS Eight week web-based dietary advice (RISTOMED platform) alone or with supplementation of VSL#3 (2 capsules per day). The RISTOMED diet was optimized to reduce inflammation and oxidative stress. MEASUREMENTS Blood and stool samples were collected on days 1 and 56. RESULTS Diet alone reduced ESR (p = 0.02), plasma levels of cholesterol (p < 0.01) and glucose (p = 0.03). Addition of VSL#3 reduced ESR (p = 0.05) and improved folate (p = 0.007), vitamin B12 (p = 0.001) and homocysteine (p < 0.001) plasma levels. Neither intervention demonstrated any further effects on inflammation. Subgroup analysis showed 40 participants without signs of low-grade inflammation (hsCRP<3 mg/l, subgroup 1) and 21 participants with low-grade inflammation at baseline (hsCRP≥3 mg/l, subgroup 2). In subgroup 2 addition of VSL#3 increased bifidobacteria (p = 0.005) in more participants and improved both folate (p = 0.015) and vitamin B12 (p = 0.035) levels compared with subgroup 1. The increases were positively correlated to the change in the bifidobacteria concentration for folate (p = 0.023) and vitamin B12 (p = 0.001). As expected change in homocysteine correlated negatively to change in folate (r = -0.629, p = 0.002) and vitamin B12 (r = -0.482, p = 0.026). CONCLUSIONS Addition of VSL#3 increased bifidobacteria and supported adequate folate and vitamin B12 concentrations in subjects with low-grade inflammation. Decrease in homocysteine with VSL#3 was clinically relevant. suggesting protective potentials for aging-associated conditions, e.g. cardiovascular or neurological diseases. ClinicalTrials.gov: NCT01069445-NCT01179789.
Collapse
Affiliation(s)
- Luzia Valentini
- Dept Gastroenterology and Hepatology, Charité-Universitätsmedizin Berlin, CCM, Charitéplatz 1, 10117 Berlin, Germany.
| | - Alessandro Pinto
- Experimental Medicine Department, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy
| | - Isabelle Bourdel-Marchasson
- CHU Bordeaux, Clinical Gerontology, France; CNRS, RMSB, UMR 5536, France; University Bordeaux, RMSB, UMR 5536, Bordeaux, France
| | - Rita Ostan
- Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Via S. Giacomo 12, 40126 Bologna, Italy
| | - Patrizia Brigidi
- Department of Pharmacy and Biotechnology, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy
| | - Silvia Turroni
- Department of Pharmacy and Biotechnology, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy
| | - Silvana Hrelia
- Dept Life Quality Studies, Alma Mater Studiorum University of Bologna, Via Irnerio 48, 40126 Bologna, Italy
| | - Patrizia Hrelia
- Department of Pharmacy and Biotechnology, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy
| | - Stefan Bereswill
- Dept Microbiology and Hygiene, Charité-Universitätsmedizin Berlin, CBF, Hindenburgdamm 27, 12203 Berlin, Germany
| | - André Fischer
- Dept Microbiology and Hygiene, Charité-Universitätsmedizin Berlin, CBF, Hindenburgdamm 27, 12203 Berlin, Germany
| | - Emanuela Leoncini
- Dept Life Quality Studies, Alma Mater Studiorum University of Bologna, Via Irnerio 48, 40126 Bologna, Italy
| | - Marco Malaguti
- Dept Life Quality Studies, Alma Mater Studiorum University of Bologna, Via Irnerio 48, 40126 Bologna, Italy
| | | | | | - Liana Spazzafumo
- Biostatistical Center INRCA, Via S. Margherita 5, 60100 Ancona, Italy
| | - Fabio Buccolini
- R&D, VoxNet CEO, Via Giovanni Paisiello 32, 00198 Rome, Italy
| | - Florence Pryen
- Actial Farmaceutica Lda, Praca Severiano Ferraz 258, 09000 082 Funchal, Portugal
| | - Lorenzo Maria Donini
- Experimental Medicine Department, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy
| | - Claudio Franceschi
- Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Via S. Giacomo 12, 40126 Bologna, Italy
| | - Herbert Lochs
- Experimental Medicine Department, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy; Medical University of Innsbruck, Innrain 52, 6020 Innsbruck, Austria
| |
Collapse
|